Dr. Shune continues the case discussion by describing disease progression following second-line therapy and outlining her approach to third-line treatment selection in cGVHD. After initiating systemic ...

Strong efficacy signals showing 33% ORR, 16.6-month PFS, and 27-month OS, improving on the SOC by 2-3X in a ...

The U.S. FDA has granted fast track status to pelareorep combination therapy for some KRAS-mutant, microsatellite-stable metastatic colorectal cancers.

The sBLA is supported by results from the pivotal phase 3 TROPION-Breast02 clinical trial (NCT05374512), which evaluated the ...

Priority Review was granted by FDA for the first line metastatic TNBC treatment. Datroway significantly improved survival ...

Treating hair loss is multifaceted. Here's what a dermatologist needs you to know.

For the new study, researchers recruited 518 patients with advanced triple-positive breast cancer across 109 hospitals in the U.S., Europe, New Zealand and Australia between June 2017 and July 2021.

The school has acted strictly in line with the Ministry of Education’s textbook policy, which requires the return of all ...

Instead of another iteration, Nioh 3 reworks the foundations of the series, trading its tightly controlled, mission-based ...

Cleveland Clinic researchers have found that nearly two-thirds of patients with HER2-positive metastatic breast cancer did not receive the guideline-recommended standard of care treatment between 2015 ...

Researchers say the type 2 diabetes medication metformin may help treat age-related macular degeneration, which could prevent ...

Tilting levy funding towards younger learners may sound simple, but blunt cuts and cliff-edge defunding would choke off progression ...